Immune surveillance of antigen processing pathway
Immune surveillance of antigen processing pathway
批准号:
9287264
负责人:
Nilabh Shastri
金额:
$53.52万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-08 至 2022-02-28
关键词:
AbbreviationsAgeAlpha CellAminopeptidaseAnatomyAntigen ReceptorsAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBiological ProcessCD8-Positive T-LymphocytesCD8B1 geneCell surfaceCellsCharacteristicsComplexCytotoxic T-LymphocytesDefectDevelopmentDifferentiation AntigensEndoplasmic ReticulumEnsureFamilyGenerationsGenesGenetic PolymorphismGlycolipidsGoalsHistocompatibilityHumanI-antigenImmuneImmune EvasionImmune TargetingImmune ToleranceImmune systemImmunizeImmunologic SurveillanceIn VitroKnockout MiceLigandsLinkLocationMalignant NeoplasmsMicrobeMolecularMolecular ChaperonesMonitorMusN-terminalObesityOrthologous GenePathway interactionsPeptide HydrolasesPeptide/MHC ComplexPeptidesPhenotypeProtein IsoformsProteolysisQa-1 AntigenResearchSpecificitySurfaceT-LymphocyteT-Lymphocyte SubsetsTAP1 geneTYRP1 geneTestingThymus GlandTissue GraftsTissuesViralVirusVitaminsWild Type Mousealpha-beta T-Cell Receptorantigen processingantigenic peptide transportercytokineexperienceimprovedin vivoinsightmicrobialnovelpathogenprotein Bresponsesensortumorviral detection
中文摘要
项目总结
我们研究的长期目标是了解和操纵免疫监视途径。这个
抗原处理途径在细胞表面产生数以千计的多肽/MHC复合体(PMHC I)
CD8+T细胞的潜在配体,使其能够检测病毒或癌症。现在很明显,这一代
正常的pMHC I谱系需要ERAAP对内质网(ER)中的多肽进行修剪
与抗原加工有关的氨基肽酶。ERAAP的目标是通过病毒进行免疫逃避
该基因的多态与许多自身免疫性疾病有关。因此,监测是至关重要的
ERAAP活性,以确保CD8+T细胞有效的免疫监视。
我们早些时候已经发现,独一无二的Fl9 NONA多肽源自于
未知功能-仅由非经典MHC Ib分子Qa-1b在ERAAP中提出-
缺乏细胞。这种被称为QFL的Fl9肽/Qa-1复合体被QFL特异性CD8+T细胞识别
裂解表达该配体的靶细胞。因此,QFL-T细胞是一种检测和消除细胞的机制
患有ERAAP缺乏症。QFL-T细胞相对丰富,并与其他
与生俱来的iNKT(不变NK T细胞)和MAIT(粘膜相关不变T细胞)细胞也受
非经典的MHC Ib分子,并对各种微生物和自身抗原产生反应。
在这里,我们建议填补我们对免疫系统如何监控保真度的理解的空白
急诊室的抗原处理。我们假设QFL特异性CD8+T细胞及其作用机制
产生QFL配体是检测ERAAP抑制的保守传感器。此外,中断
ERAAP缺陷小鼠的这些机制可能导致自身免疫性肥胖。
我们将通过(A)表征αβTCR和胸腺发育途径来实现这些目标
为了让QFL-T细胞了解这些细胞是如何产生的并获得其独特的功能,(B)定义
通过分析Fam49a/b前体进入QFL配体的过程来产生QFL配体的分子步骤
(C)确定QFL-T的解剖位置(S)和功能(S)
正常WT小鼠以及肥胖的ERAAP-/-小鼠体内的细胞。
相关性
当对自身抗原的免疫耐受性被破坏时,就会产生自身免疫。了解自身抗原是如何
是由蛋白水解酶产生的,可能会揭示干预自身免疫性疾病的潜在方法。
英文摘要
Project summary
The long term goal of our research is to understand and manipulate immune surveillance pathways. The
antigen processing pathway yields thousands of peptide/MHC complexes (pMHC I) on the cell surface as
potential ligands for CD8+ T cells to allow detection of viruses or cancer. It is now clear that generation of the
normal pMHC I repertoire requires peptide trimming in the endoplasmic reticulum (ER) by ERAAP, the ER
aminopeptidase associated with antigen processing. The ERAAP is targeted for immune evasion by viruses
and polymorphisms in this gene are linked to many autoimmune diseases. It is therefore essential to monitor
ERAAP activity to ensure effective immune surveillance by CD8+ T cells.
We had discovered earlier that the unique FL9 nona peptide — derived from the Fam49a/b proteins of
unknown function — was presented by the non-classical MHC Ib molecule called Qa-1b only in ERAAP-
deficient cells. This FL9 peptide/Qa-1 complex, called QFL was recognized by QFL-specific CD8+ T cells which
lysed target cells expressing this ligand. Thus QFL- T cells are a mechanism for detecting and eliminating cells
with ERAAP-deficiency. The QFL-T cells are relatively abundant, and share key characteristics with other
innate-like iNKT (invariant NK T) and MAIT (mucosal - associated invariant T) cells which are also restricted by
non-classical MHC Ib molecules and respond to various microbial and self-antigens.
Here we propose to fill gaps in our understanding of how the immune system monitors the fidelity of
antigen processing in the ER. We hypothesize that QFL-specific CD8+ T cells and the mechanisms for
generating the QFL-ligand are conserved sensors for detecting ERAAP-inhibition. Furthermore, disruption of
these mechanisms in ERAAP-deficient mice may result in autoimmune obesity.
We will accomplish these goals by (a) characterizing the αβ TCRs and the thymic developmental pathway
for QFL-T cells to understand how these cells arise and acquire their unique functions, (b) defining the
molecular steps for generating the QFL-ligand by analyzing the processing of Fam49a/b precursors into the
FL9 peptide for loading the Qa-1 MHC Ib, and (c) defining the anatomical location(s) and function(s) of QFL-T
cells in normal WT mice as well as their obese ERAAP-/- counterparts.
Relevance
Autoimmunity results when immune tolerance to self-antigens is disrupted. Understanding how self-antigens
are produced by proteolytic enzymes will likely reveal potential ways to intervene in autoimmune disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unconventional sources of peptides for antigen presentation
-
批准号:9237812
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2017
-
负责人:Nilabh Shastri
-
依托单位:
HLA-peptide repertoire in autoimmunity
-
批准号:8583218
-
项目类别:
-
资助金额:$19.95万
-
财政年份:2013
-
负责人:Nilabh Shastri
-
依托单位:
Immune surveillance via non-classical MHC class Ib molecules
-
批准号:8503599
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2012
-
负责人:Nilabh Shastri
-
依托单位:
Immune surveillance via non-classical MHC class Ib molecules
-
批准号:8358263
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2012
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7173914
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7728304
-
项目类别:
-
资助金额:$37.76万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:8235736
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:8588887
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:8390469
-
项目类别:
-
资助金额:$35.36万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7008884
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7342495
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:9104281
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:8774873
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:7895817
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:6850117
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Antigen processing in the secretory pathway
-
批准号:6784301
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2004
-
负责人:Nilabh Shastri
-
依托单位:
Generating Antigenic Peptide/MHC By Cryptic Translation
-
批准号:7195935
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2000
-
负责人:Nilabh Shastri
-
依托单位:
GENERATING ANTIGENIC PEPTIDE/MHC BY CRYPTIC TRANSLATION
-
批准号:6697042
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2000
-
负责人:Nilabh Shastri
-
依托单位:
GENERATING ANTIGENIC PEPTIDE/MHC BY CRYPTIC TRANSLATION
-
批准号:6044315
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2000
-
负责人:Nilabh Shastri
-
依托单位:
Generating Antigenic Peptide/MHC By Cryptic Translation
-
批准号:7482461
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2000
-
负责人:Nilabh Shastri
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: